Team
Thioredoxin Systems AB is a growing organisation, supported by an expert advisory board, dedicated to the development of EbsArgent® as a new solution to antimicrobial resistance.
BOARD OF DIRECTORS
Anna-Lena Sventelius
CHAIRMAN OF THE BOARD
als@txnsystems.com
An experienced published and editor-in-chief with almost 30 years’ experience in journalistic publishing for esteemed media companies like Bonnier Magazines & Brands. Anna-Lena is the daughter of company founder Arne Holmgren and has been devoted to seeing his company continue the development of his patents and scientific discoveries after his passing.
“Our father Arne Holmgren really lived for his science. Me and my brother Magnus are very happy to be able to run Arne’s patents and company, Thioredoxin Systems AB, together with a very competent group of people.”
Magnus Holmgren
BOARD MEMBER
mh@txnsystems.com
A pioneer in radio access networks and has over 20 years’ experience in telecom systems and developing mobile data. Magnus has extensive experience in line management. He is the son of the late Arne Holmgren and driven by the wish to progress his father’s science in the hope that it can contribute to a solution to antibiotic resistance and the threat that it’s posing against the humanity.
“Resistant bacteria is a big threat against the humanity. If our father Arne Holmgren’s science can contribute to a solution, me and my sister Anna-Lena would both be incredibly proud.”
Peter Holm, PhD
BOARD MEMBER
ph@txnsystems.com
A European Patent Attorney with a PhD in biochemistry and biophysics from Karolinska Institutet. Peter is a partner and country manager for Sweden at the patent law firm Høiberg. He has conducted research as a guest researcher at renowned institutions such as Yale University, Kyoto University and at Institut Curie. He is also an expert in strategic IP counselling for life science companies and supports a number of Scandinavian pharmaceutical companies as advisor and board member.
Mohamad Takwa, PhD
BOARD MEMBER & BUSINESS ADVISOR
mt@txnsystems.com
With a PhD in Biotechnology and 20 years of experience in the life sciences field, he has built a track record of translating cutting-edge science into products and companies. He has co-founded, led and exited multiple biotech and MedTech ventures. His expertise spans integrating innovation with business strategy, driving complex projects to success, and fostering cross-disciplinary collaborations. His contributions to diagnostics, therapeutics, and industrial biotechnology have consistently delivered high-impact solutions.
Prof. Elias S.J. Arnér, MD PhD
BOARD MEMBER & CEO
ea@txnsystems.com
A world-renowned scientist in redox biology and biotechnological applications with more than 170 publications and four granted patents, who succeeded Prof. Arne Holmgren as head of the Division of Biochemistry at MBB, Karolinska Institutet. Elias has effectively translated his successful academic research into commercial ventures within biotechnology and medicine, bridging scientific ingenuity with real-world impact. Through astute leadership and exceptional business intelligence he has promoted fast-paced technology development and efficient market entry of several companies, fostering innovation.
